Axsome Therapeutics (AXSM) Change in Inventory (2022 - 2026)

Axsome Therapeutics (AXSM) has 5 years of Change in Inventory data on file, last reported at $3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 1149.0% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $13.5 million (up 2353.5% YoY), and the FY2025 full-year result was $10.7 million, up 1532.8% from the prior year.
• Change in Inventory declined to $3.1 million in Q1 2026, from $3.6 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $5.0 million in Q3 2025 to a low of -$1.7 million in Q3 2023.
• A 5-year average of $1.5 million and a median of $1.3 million in 2023 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory sank 681.82% in 2023 and surged 1149.0% in 2026, its largest moves.
• Tracing AXSM's Change in Inventory over 5 years: stood at $1.3 million in 2022, then surged by 269.74% to $4.9 million in 2023, then tumbled by 76.9% to $1.1 million in 2024, then jumped by 222.41% to $3.6 million in 2025, then declined by 14.56% to $3.1 million in 2026.
• Business Quant data shows AXSM's Change in Inventory at $3.1 million in Q1 2026, $3.6 million in Q4 2025, and $5.0 million in Q3 2025.